Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments.
Researchers at the Korea Research Institute of Chemical Technology…
Novel cancer immunotherapy approach could complement existing CAR-T treatments
